Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
150
datasets available to search
ShareScore release 0.9.0
Dataset results
150 results for “amyloid beta”
Predictive and Diagnostic Value of Tau and Beta-amyloid Markers in the Dementia of Parkinson's Disease
ClinicalTrials.gov study NCT02243982. IPD Sharing: Not stated. Countries: 1. Publications: 16.
Amyloid Beta-peptide 1-40 and Alzheimer's Disease
ClinicalTrials.gov study NCT02770482. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study Investigating the Effects of JNJ-54861911 on Amyloid-beta Processing in Cerebrospinal Fluid (CSF) and Plasma in Japanese Participants Asymptomatic at Risk for Alzheimer Dementia
ClinicalTrials.gov study NCT02360657. IPD Sharing: Not stated. Countries: 1. Publications: 1.
[18F]Florbetazine ([18F]92) for Beta Amyloid PET Imaging in Alzheimer's Disease
ClinicalTrials.gov study NCT06141356. IPD Sharing: NO. Countries: 1. Publications: 1.
The Effect of Short-Term Statins and NSAIDs on Levels of Beta-Amyloid, a Protein Associated With Alzheimer's Disease
ClinicalTrials.gov study NCT00046358. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Beta Amyloid PET/CT in Various Aβ-Related Disease
ClinicalTrials.gov study NCT06725706. IPD Sharing: NO. Countries: 1. Publications: 1.
The Study of microRNA 107 (miRNA 107) and Beta-amyloid Precursor Protein-cleaving Enzyme 1 (BACE1) Messenger Ribonucleic Acid (mRNA) Gene Expression in Cerebrospinal Fluid and Peripheral Blood of Alzh
ClinicalTrials.gov study NCT01819545. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Study to Evaluate the Effect of CT1812 Treatment on Amyloid Beta Oligomer Displacement Into CSF in Subjects With Mild to Moderate Alzheimer's Disease
ClinicalTrials.gov study NCT03522129. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Effect of Bexarotene on Beta-Amyloid and Apolipoprotein E Metabolism in Healthy Subjects
ClinicalTrials.gov study NCT02061878. IPD Sharing: Not stated. Countries: 1. Publications: 1.
CNS and Plasma Amyloid-Beta Kinetics in Alzheimer's Disease
ClinicalTrials.gov study NCT02021682. IPD Sharing: NO. Countries: 1. Publications: 2.
Brain Sleep Clearance of Amyloid-Beta Peptides
ClinicalTrials.gov study NCT02474251. IPD Sharing: Not stated. Countries: 1. Publications: 5.
Effects of Sleep Deprivation on Cerebrospinal Fluid (CSF) Amyloid-beta (Aβ) Dynamics
ClinicalTrials.gov study NCT01194713. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Clinical Trial to Explore the the Amyloid Beta Draining Effect of Thiethylperazine (TEP) in Subjects With Newly Diagnosed Early-to-mild Dementia Due to Alzheimer's Disease (AD) in Comparison to Health
ClinicalTrials.gov study NCT03417986. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response.
ClinicalTrials.gov study NCT00765115. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study to Evaluate the Effects of JNJ-54861911 on Amyloid Beta Processing in Cerebrospinal Fluid and Plasma in Patients With Prodromal Alzheimer's Disease
ClinicalTrials.gov study NCT01978548. IPD Sharing: Not stated. Countries: 4. Publications: 1.
Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old
Open the record for dataset details and reuse information.
optoacoustic tomography beta-amyloid imaging
<p>The abnormal deposition of fibrillar beta-amyloid (Aβ) deposits in the brain is one of the major histopathological hallmarks of Alzheimer’s disease (AD). Here we describe a novel 3D high-resolution whole brain imaging method to quantify brain Aβ deposits by using non-invasive optoacoustic tomography in<em> </em>arcAβ and APP/PS1 transgenic mouse models of cerebral amyloidosis.</p>
Supporting Data for computational analysis in Nanoplastics Potentiate Alzheimer's Pathogenesis by Promoting the Microglial Escape of Amyloid Beta
Open the record for dataset details and reuse information.
Efficacy and Safety of Plasma Exchange With 5% Albumin in Beta-amyloid Peptide Clearance in Cerebral Spinal Fluid
ClinicalTrials.gov study NCT00742417. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Sleep Quality and Amyloid-Beta Kinetics
ClinicalTrials.gov study NCT03077620. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.